Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination

A single dose of BNT162b2 vaccine is suggested for COVID‐19‐infected individuals to reduce side effects due to release of inflammatory mediators such as oral lichen planus (OLP).

Detalles Bibliográficos
Autor principal: Zargaran, Massoumeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307884/
https://www.ncbi.nlm.nih.gov/pubmed/35898746
http://dx.doi.org/10.1002/ccr3.6126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307884/
https://www.ncbi.nlm.nih.gov/pubmed/35898746
http://dx.doi.org/10.1002/ccr3.6126

Ejemplares similares